nervous system
• abnormal Remak fibers with an increase in membranous structures
|
• attenuated Schwann cell processes are occasionally observed
|
• abnormally large numbers of small axons are observed in some animals
|
• atrophic fibers are occasionally observed
|
• myelination is delayed and never reaches control levels
• the phenotype is more severe than in Tg(PMP22)C22Fbas mice
|
• peroneal nerve fibers from 3 week old mice are thinly myelinated or amyelinated as compared to wild-type
• a greater proportion of the abnormal fibers are found in the motor branch of the femoral nerve
• lumbar ventral roots have a higher proportion of abnormal fibers than dorsal roots or peripheral nerves
• 74% of peroneal and femoral nerve fibers are normally myelinated at 3 weeks increasing to 84% in adults, but never reaching 100%
|
• small diameter fibers are hypermyelinated
|
• mean compound muscle action potential (CMAP) amplitude is decreased in adults, but not young mice, as compared to wild-type, but higher than in Tg(PMP22)C22Fbas mice
• mean compound nerve action potential (CNAP) amplitude is decreased as compared to wild-type, but higher than Tg(PMP22)C22Fbas mice
|
• mean nerve conduction velocity is decreased as compared to wild-type, but higher than in Tg(PMP22)C22Fbas mice
|
behavior/neurological
• neuromuscular SHIRPA scores are increased from week 3 to 24 indicating a decrease in performance, particularly in tremor, gait, tail elevation, touch escape, grip strength and wire maneuver
• scores are higher than wild-type, but less than Tg(PMP22)C22Fbas mice
|
• reduced locomotor activity as compared to wild-type
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Charcot-Marie-Tooth disease type 1A | DOID:0110148 |
OMIM:118220 |
J:237901 |